Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models.

Front Pharmacol · 2018 · PMC5788961 · PMID 29422864

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Correlation between observed and predicted DAS28 after 6 months of MTX monotherapy was highly significant ( p < 0.0001, ρ = 0.55; 95% CI:0.40; 0.67), with 30.3% of variability explained.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.